R
Market Data
$30.85+$3.97 (+14.77%)
RAPP · Last trade
Prev Close
$26.88
Range (29d)
$26.85 – $30.85
Recent Filings
- SC 13G232.0 KBRapport Therapeutics, Inc.Nov 14, 5:13 PM ET·0001072613-24-000885
- SC 13G/A86.4 KBRapport Therapeutics, Inc.Nov 14, 3:11 PM ET·0001172661-24-005064
- SC 13G18.3 KBRapport Therapeutics, Inc.Nov 13, 12:26 PM ET·0001562230-24-000082
- SC 13G/A8.3 KBRapport Therapeutics, Inc.Nov 12, 10:34 AM ET·0000315066-24-002916
- 10-Q9.0 MBRapport Therapeutics, Inc.Nov 7, 7:30 AM ET·0000950170-24-122801
- 8-K375.1 KBRapport Therapeutics, Inc.Nov 7, 7:15 AM ET·0000950170-24-122792
- SC 13G51.9 KBRapport Therapeutics, Inc.Oct 18, 5:23 PM ET·0000904454-24-000538
- 10-Q9.1 MBRapport Therapeutics, Inc.Aug 8, 7:40 AM ET·0000950170-24-093334
- 8-K457.2 KBRapport Therapeutics, Inc.Aug 8, 7:20 AM ET·0000950170-24-093321
- SC 13G8.0 KBRapport Therapeutics, Inc.Jul 10, 10:10 AM ET·0000315066-24-001831
Insiders
10- ARCH Venture Fund XII, L.P.10% Owner
- Bredt DavidChief Scientific Officer
- Burow Kristina10% Owner
- Burrell Terry-AnnDirector
- Ceesay AbrahamDirector, Chief Executive Officer
- CRANDELL KEITH10% Owner
- Galer Bradley S.Chief Medical Officer
- Gault CherylChief Operations Officer
- GILLIS STEVEN10% Owner
- HEALY JAMESDirector
Tickers
Addresses
business
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
mailing
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
Former Names
- Rapport Therapeutics, Inc.2025-12-18